Washington Post: As China nears a coronavirus vaccine, bribery cloud hangs over drugmaker Sinovac

Washington Post: As China nears a coronavirus vaccine, bribery cloud hangs over drugmaker Sinovac. “Chinese coronavirus-vaccine maker Sinovac Biotech is good at getting its products to market. It was first to begin clinical trials of a SARS vaccine in 2003 and first to bring a swine flu vaccine to consumers in 2009. Its CEO was also bribing China’s drug regulator for vaccine approvals during that time, court records show.”

Leave a Reply